REQUEST A DEMO
Total
USD $0.00
Search more companies

Comercializadora-Bak-Pharma S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Comercializadora-Bak-Pharma S.A.S. Profile Updated: September 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Comercializadora-Bak-Pharma S.A.S. is an enterprise based in Ecuador. Its main office is in Quito. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Comercializadora-Bak-Pharma S.A.S. was incorporated on September 30, 2021. There are currently 2 (2024) people employed by Comercializadora-Bak-Pharma S.A.S.. There was a net sales revenue drop of 29.97% reported in Comercializadora-Bak-Pharma S.A.S.’s latest financial highlights for 2024. Its total assets decreased by 33.8% over the same period.

Headquarters
Calle Republica Dominicana, N80-50
Quito; Pichincha;

Contact Details: Purchase the Comercializadora-Bak-Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Comercializadora-Bak-Pharma S.A.S. report to view the information.
Registered Capital:
Purchase the Comercializadora-Bak-Pharma S.A.S. report to view the information.
Financial Auditors:
Purchase the Comercializadora-Bak-Pharma S.A.S. report to view the information.
Incorporation Date:
September 30, 2021
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Comercializadora-Bak-Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-29.97%
Total operating revenue
-29.97%
Operating profit (EBIT)
-75.78%
EBITDA
-75.78%
Total Assets
-33.8%
Total Equity
1097.63%
Operating Profit Margin (ROS)
-1.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?